Insulin Glargine And Lixisenatide + Octreotide Interaction
Moderateinteraction on record
Description
Somatostatin analog that may increase the risk of hypoglycemia. Dose reductions and increased frequency of glucose monitoring may be required.
Mechanism
Increases risk of hypoglycemia
Source: NLP:insulin glargine and lixisenatide